Get started
Author

Tamer Mahmoud Elbaz

Observed names: Elbaz, T., Elbaz, Tamer, T. Elbaz, T.M. Elbaz, Tamer ELBAZ, Tamer El-Baz, Tamer Elbaz, Tamer Elbaz Elbaz, Tamer M ElBaz, Tamer M Elbaz, Tamer M. Elbaz, Tamer M. elbaz, Tamer Mahmoud El Baz, Tamer Mahmoud El-Baz, TamerMahmoud Elbaz, Tamerl Elbaz
Observed institutions: Cairo University, Ghent University, Clinica Universidad de Navarra, Cairo University hospitals, New Giza University, Helwan University
ORCID: 0000-0003-0816-9575
Observed ORCID: 0000-0003-0816-9575
OpenAlex ID: A5014616468
Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium
2016 · Ju Dong Yang, Essa A Mohamed, et al. · ˜The œLancet. Gastroenterology & hepatology · 279
PDF
Hepatic and Intestinal Schistosomiasis: Review
2013 · Tamer Elbaz, Gamal Esmat · Journal of Advanced Research · 203
PDF
Human Schistosomiasis: Clinical Perspective: Review
2013 · Rashad S. Barsoum, Gamal Esmat, et al. · Journal of Advanced Research · 187
PDF
Efficacy and survival analysis of percutaneous radiofrequency versus microwave ablation for hepatocellular carcinoma: an egyptian multidisciplinary clinic experience
2014 · Ashraf Abdelaziz, Tamer Elbaz, et al. · Surgical Endoscopy · 144
Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real‐world results from 18 378 patients in Egypt
2017 · H. Omar, W. El Akel, et al. · Alimentary Pharmacology & Therapeutics · 129
Machine Learning Prediction Models for Diagnosing Hepatocellular Carcinoma with HCV-related Chronic Liver Disease
2020 · Somaya Hashem, Mahmoud ElHefnawi, et al. · Computer Methods and Programs in Biomedicine · 90
HCV in Egypt, prevention, treatment and key barriers to elimination
2018 · Mohamed El Kassas, Tamer Elbaz, et al. · Expert Review of Anti-infective Therapy · 62
New era for management of chronic hepatitis C virus using direct antiviral agents: A review
2014 · Tamer Elbaz, Mohamed El-Kassas, et al. · Journal of Advanced Research · 62
PDF
Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients
2016 · Rasha Eletreby, Wafaa Elakel, et al. · Liver International · 61
Survival and Prognostic Factors for Hepatocellular Carcinoma: an Egyptian Multidisciplinary Clinic Experience
2014 · Ashraf Omar Abdelaziz, Tamer Mahmoud Elbaz, et al. · Asian Pacific Journal of Cancer Prevention · 52
PDF
Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma
2015 · Eman Medhat, Ashraf Abdel Aziz, et al. · Journal of Digestive Diseases · 48
Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis
2015 · Ashraf Omar Abdelaziz, Mohamed Mahmoud Nabeel, et al. · Scandinavian Journal of Gastroenterology · 45
Safety of direct antiviral agents in the management of hepatitis C
2016 · Mohamed El Kassas, Tamer Elbaz, et al. · Expert Opinion on Drug Safety · 43
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study
2021 · Mahmoud El-Bendary, Sherief Abd-Elsalam, et al. · Expert Review of Anti-infective Therapy · 41
Transarterial Chemoembolization Combined with Either Radiofrequency or Microwave Ablation in Management of Hepatocellular Carcinoma
2017 · Ashraf Omar Abdelaziz, Ahmed Hosni Abdelmaksoud, et al. · PubMed · 40
Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma
2015 · Nevine El-Abd, Amal Fawzy, et al. · Tumor Biology · 39
Pregnancy outcome of anti‐HCV direct‐acting antivirals: Real‐life data from an Egyptian cohort
2021 · Mohamed AbdAllah, Mohamed Alboraie, et al. · Liver International · 38
Tumor behavior of hepatocellular carcinoma after hepatitis C treatment by direct-acting antivirals: comparative analysis with non-direct-acting antivirals-treated patients
2018 · Ashraf O. Abdelaziz, Mohamed M. Nabil, et al. · European Journal of Gastroenterology & Hepatology · 37
Efficacy and safety of sofosbuvir and daclatasvir with or without ribavirin in elderly patients with chronic hepatitis C virus infection
2018 · Tamer Elbaz, Mahmoud Abdo, et al. · Journal of Medical Virology · 29
Novel scores combining AFP with non‐invasive markers for prediction of liver fibrosis in chronic hepatitis C patients
2018 · Mohamed Gamil, Mohamed Alboraie, et al. · Journal of Medical Virology · 28
De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus
2017 · Ashraf O. Abdelaziz, Mohamed M. Nabil, et al. · European Journal of Gastroenterology & Hepatology · 28
Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt
2020 · Gamal Esmat, Tamer Elbaz, et al. · Expert Review of Anti-infective Therapy · 26
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
2023 · Ashraf Omar, Ahmed Kaseb, et al. · Journal of Hepatocellular Carcinoma · 25
PDF
Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4
2017 · Gamal Esmat, Tamer Elbaz, et al. · Journal of Hepatology · 25
Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review
2019 · Mohamed El Kassas, Tamer Elbaz, et al. · Journal of Advanced Research · 23
PDF
Works count: 110
Citation count: 2,252
H-index: 24
I10-index: 45
Year
Topic
Type